Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 10, 2009 - Issue 18
Submit an article Journal homepage
173
Views
5
CrossRef citations to date
0
Altmetric
Clinical Trial Evaluation

Telmisartan prevents cardiovascular events in a broad group of at-risk patients

Evaluation of: Yusuf S, Teo KK, Pogue J, et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008;358(15):1547-59

Magnus Baumhäkel University Hospital of the Saarland, Department of Cardiology, Kirrbergerstr. 66421 Homburg Saar, Germany +49 0 6841 16 23000; +49 6847 16 23369; [email protected]
&
Michael Böhm University of the Saarland, Department of Internal Medicine III, Homburg Saar, Germany
Pages 3113-3117 | Published online: 19 Nov 2009

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.